Agreed to an extent, keeping one eye on history the goalposts do seem to shift a lot.
However, it took up until a few months ago to achieve the stated aim of a megabit chip, as various technical issues surfaced throughout the development process. It's going to take longer than those few months for companies to sit up and take notice, do their feasibility studies and decide whether/what they should bid.
A 20 nm Megabit platform at IMEC is now available - it would be madness not to take development there while we are waiting - we're talking about the opportunity to really blow DRAM out of the water at that node size, for the matter of a few hundred K in development costs. The cost to return ratio on a successful 20 nm chip is huge IMO.
To have IMEC agree to prioritise that next step is a great advertisement to potential acquirers in of itself.
The company can't sit on its hands in the meantime - the opportunity exists to step up the development of the tech significantly - they have to go for it. The best thing is they are fully funded and then some for this work.
- Forums
- ASX - By Stock
- 4DS
- CXO888 / any other attendees
CXO888 / any other attendees, page-60
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
|
|||||
Last
8.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 297513 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 0.090 |
3 | 64842 | 0.088 |
11 | 775652 | 0.087 |
6 | 1026804 | 0.086 |
12 | 1362571 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 297513 | 2 |
0.090 | 313381 | 2 |
0.091 | 11445 | 1 |
0.092 | 683892 | 3 |
0.093 | 181179 | 3 |
Last trade - 08.06am 16/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online